Markets OpenAI’s New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can’t Use It April 18, 2026 By The Coin Weekly This post was originally published on this siteGPT-Rosalind is OpenAI’s first domain-specific model, built for drug discovery and life sciences—and it’s not for everyone. Share FacebookTwitterPinterestWhatsApp Latest stories Markets GalaxyOne Head Wants Retail Investors to Stake More, Predict Less The Coin Weekly - April 18, 2026 AI Circle unveils USDC Bridge for native cross-chain stablecoin transfers The Coin Weekly - April 18, 2026 Markets Bitcoin Cracks 7-Month Ceiling. Can Bulls Push It Higher? The Coin Weekly - April 17, 2026 Markets You Can Now Use XRP on Solana—Here’s How The Coin Weekly - April 17, 2026 Markets Rep. Sheri Biggs Doubles Down on Bitcoin, Buys Up to $250K of BlackRock’s ETF The Coin Weekly - April 17, 2026 - Advertisement - You might also like... Markets GalaxyOne Head Wants Retail Investors to Stake More, Predict Less The Coin Weekly - April 18, 2026 Markets Bitcoin Cracks 7-Month Ceiling. Can Bulls Push It Higher? The Coin Weekly - April 17, 2026 Markets You Can Now Use XRP on Solana—Here’s How The Coin Weekly - April 17, 2026